ReShape Lifesciences Inc
General ticker "RSLS" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $2.6M
ReShape Lifesciences Inc does not follow the US Stock Market performance with the rate: -35.5%.
Estimated limits based on current volatility of 4.2%: low 4.29$, high 4.67$
Factors to consider:
- US accounted for 82.1% of revenue in the fiscal year ended 2022-12-31
- Current price 16.2% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [5.08$, 23.71$]
- 2024-12-30 to 2025-12-30 estimated range: [2.43$, 10.57$]
Short-term RSLS quotes
Long-term RSLS plot with estimates
Financial data
YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|
Operating Revenue | $13.60MM | $10.71MM | $8.68MM |
Operating Expenses | $71.48MM | $57.06MM | $23.32MM |
Operating Income | $-57.88MM | $-46.35MM | $-14.64MM |
Non-Operating Income | $-5.54MM | $-0.24MM | $3.30MM |
Interest Expense | $0.83MM | $0.11MM | $0.00MM |
R&D Expense | $2.52MM | $2.54MM | $2.31MM |
Income(Loss) | $-63.42MM | $-46.59MM | $-11.34MM |
Taxes | $-0.27MM | $-0.38MM | $0.05MM |
Profit(Loss) | $-63.15MM | $-46.21MM | $-11.39MM |
Stockholders Equity | $44.33MM | $3.66MM | $6.66MM |
Inventory | $3.00MM | $3.61MM | $3.74MM |
Assets | $52.53MM | $11.14MM | $10.66MM |
Operating Cash Flow | $-15.38MM | $-21.90MM | $-16.96MM |
Capital expenditure | $0.35MM | $0.13MM | $0.04MM |
Investing Cash Flow | $1.85MM | $-0.09MM | $-0.01MM |
Financing Cash Flow | $33.30MM | $3.13MM | $17.57MM |
Earnings Per Share* | $-16,438.36 | $-6,316.20 | $-110.88 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.